Socks David A
Director at PHAT; SVP at CADENCE PHARMACEUTICALS INC
- Sold, on record
- $19.3M
- Dollars the filings state
- Form 4 sales
- 25
- Latest Oct 8, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PHATPhathom Pharmaceuticals, Inc.Director
- CADENCE PHARMACEUTICALS INCSVP
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- PHAT449,000 shares
- CADENCE PHARMACEUTICALS INC145,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PHATPlan not statedFeb 23, 2021 2021
Sold 70,000 shares at $46.49 ($3.3M)
Socks David A, Director
Sold 4.6% of holdings ($70M position)1.4M shares left1.8x usual sizeFiling
- 2 Form 4 sale PHATPlan not statedMar 12, 2021 +17 days
Sold 55,000 shares at $47.58 ($2.6M)
Socks David A, Director
Sold 3.8% of holdings ($68.3M position)1.4M shares left1x usual sizeFiling
- 3 Form 4 sale PHATPlan not statedApr 6, 2021 +25 days
Sold 40,000 shares at $36.55 ($1.5M)
Socks David A, Director
Sold 2.9% of holdings ($50.5M position)1.3M shares left0.7x usual sizeFiling
- 4 Form 4 sale PHATPlan not statedMay 20, 2021 +44 days
Sold 40,000 shares at $32.64 ($1.3M)
Socks David A, Director
Sold 3% of holdings ($43.8M position)1.3M shares left0.8x usual sizeFiling
- 5 Form 4 sale PHATPlan not statedJun 29, 2021 +40 days
Sold 40,000 shares at $34.05 ($1.4M)
Socks David A, Director
Sold 3.1% of holdings ($44.3M position)1.3M shares left1x usual sizeFiling
- 6 Form 4 sale PHATPlan not statedAug 16, 2021 +48 days
Sold 18,000 shares at $31.25 ($563k)
Socks David A, Director
Sold 1.4% of holdings ($39.5M position)1.2M shares left0.5x usual sizeFiling
- 7 Form 4 sale PHATPlan not statedSep 22, 2021 +37 days
Sold 18,000 shares at $32.63 ($587k)
Socks David A, Director
Sold 1.4% of holdings ($40.7M position)1.2M shares left0.5x usual sizeFiling
- 8 Form 4 sale PHATPlan not statedOct 8, 2021 +16 days
Sold 18,000 shares at $32.57 ($586k)
Socks David A, Director
Sold 1.5% of holdings ($40M position)1.2M shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2021 | Oct 8, 2021 | PHAT | Director | Form 4 sale | 18,000 | $586k | 1.5% | Plan not stated | SEC |
| Sep 22, 2021 | Sep 23, 2021 | PHAT | Director | Form 4 sale | 18,000 | $587k | 1.4% | Plan not stated | SEC |
| Aug 16, 2021 | Aug 18, 2021 | PHAT | Director | Form 4 sale | 18,000 | $563k | 1.4% | Plan not stated | SEC |
| Jun 29, 2021 | Jun 29, 2021 | PHAT | Director | Form 4 sale | 40,000 | $1.4M | 3.1% | Plan not stated | SEC |
| May 20, 2021 | May 21, 2021 | PHAT | Director | Form 4 sale | 40,000 | $1.3M | 3.0% | Plan not stated | SEC |
| Apr 6, 2021 | Apr 7, 2021 | PHAT | Director | Form 4 sale | 40,000 | $1.5M | 2.9% | Plan not stated | SEC |
| Mar 12, 2021 | Mar 12, 2021 | PHAT | Director | Form 4 sale | 55,000 | $2.6M | 3.8% | Plan not stated | SEC |
| Feb 23, 2021 | Feb 23, 2021 | PHAT | Director | Form 4 sale | 70,000 | $3.3M | 4.6% | Plan not stated | SEC |
| Jan 12, 2021 | Jan 13, 2021 | PHAT | Director | Form 4 sale | 40,000 | $1.4M | 2.5% | Plan not stated | SEC |
| Dec 17, 2020 | Dec 18, 2020 | PHAT | Director | Form 4 sale | 79,658 | $3.5M | 4.8% | Plan not stated | SEC |
| Nov 11, 2020 | Nov 12, 2020 | PHAT | Director | Form 4 sale | 30,342 | $1.3M | 1.8% | Plan not stated | SEC |
| Jun 14, 2010 | Jun 15, 2010 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 10,000 | $71k | 9.4% | Plan not stated | SEC |
| May 10, 2010 | May 11, 2010 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 10,000 | $92k | 8.6% | Plan not stated | SEC |
| Apr 19, 2010 | Apr 20, 2010 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 5,000 | $50k | 4.1% | Plan not stated | SEC |
| Apr 12, 2010 | Apr 13, 2010 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 10,000 | $93k | 7.6% | Plan not stated | SEC |
| Mar 8, 2010 | Mar 9, 2010 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 10,000 | $93k | 7.1% | Plan not stated | SEC |
| Feb 8, 2010 | Feb 9, 2010 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 12,500 | $128k | 8.1% | Plan not stated | SEC |
| Jan 11, 2010 | Jan 12, 2010 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 12,500 | $126k | 7.5% | Plan not stated | SEC |
| Dec 17, 2009 | Dec 18, 2009 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 2,500 | $25k | 1.7% | Plan not stated | SEC |
| Dec 14, 2009 | Dec 16, 2009 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 10,000 | $93k | 6.5% | Plan not stated | SEC |
| Nov 9, 2009 | Nov 10, 2009 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 12,500 | $125k | 7.5% | Plan not stated | SEC |
| Oct 12, 2009 | Oct 13, 2009 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 12,500 | $145k | 7.0% | Plan not stated | SEC |
| Sep 14, 2009 | Sep 15, 2009 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 12,500 | $134k | 6.5% | Plan not stated | SEC |
| Aug 10, 2009 | Aug 12, 2009 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 12,500 | $137k | 6.1% | Plan not stated | SEC |
| Jul 13, 2009 | Jul 15, 2009 | CADENCE PHARMACEUTICALS INC | SVP | Form 4 sale | 12,500 | $129k | 5.8% | Plan not stated | SEC |